Oncolys BioPharma Inc. (TYO:4588)
Japan · Delayed Price · Currency is JPY 2,338.00
+54.00 (2.36%)
At close: Mar 27, 2026
Oncolys BioPharma Market Cap
Oncolys BioPharma has a market cap or net worth of 68.44 billion as of March 27, 2026. Its market cap has increased by 302.50% in one year.
Market Cap
68.44B
Enterprise Value
67.43B
Revenue
28.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,338.00
Market Cap Chart
Since December 6, 2013, Oncolys BioPharma's market cap has increased from 23.62B to 68.44B, an increase of 189.79%. That is a compound annual growth rate of 9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 68.44B | 72.89% |
| Dec 30, 2025 | 39.59B | 207.33% |
| Dec 30, 2024 | 12.88B | 18.41% |
| Dec 29, 2023 | 10.88B | 19.14% |
| Dec 30, 2022 | 9.13B | -0.44% |
| Dec 30, 2021 | 9.17B | -58.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 180.93B |
| PeptiDream | 154.60B |
| SanBio Company | 146.70B |
| Takara Bio | 138.24B |
| Nxera Pharma | 81.90B |
| Cuorips | 58.59B |
| Healios K.K. | 51.03B |
| Stella Pharma | 29.98B |